KOL kliniske forsøg i Colorado
15 studier for KOL søger deltagere på steder i Colorado.
Byer i Colorado
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Aurora
- Research Site, Denver
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005, Boulder
- Critical Care Pulmonary & Sleep Associates- Site Number : 8400081, Lakewood
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Lynn Institute of Denver, Aurora
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- National Jewish Health Medical Center, Denver
RekruttererFase 2
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- UCHealth - Medical Center of the Rockies, Loveland
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 17. sep. 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- National Jewish Health, Denver
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lakewood
RekruttererFase 3
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339MoblO2 to Maintain Oxygenation
- National Jewish Health, Denver
Rekrutterer
Alder 25 til 95 · Alle køn · Opdateret 22. jul. 2026 · NCT07704567SPIROMICS Study of Early COPD Progression (SOURCE)
- National Jewish Health, Denver
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 30 til 55 · Alle køn · Opdateret 3. jun. 2026 · NCT05033990Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
RekruttererFase 2
Alder 35 til 89 · Alle køn · Opdateret 15. maj 2026 · NCT05937854Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT05896579Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT07576894Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Aurora
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- National Jewish Health, Denver
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 16. jan. 2026 · NCT06505603PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- University of Colorado, Denver
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 12. okt. 2023 · NCT05306743Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.